Quarterly Statement Of Cash Flows

KYORIN Pharmaceutical Co., Ltd. - Filing #7717525

Concept 2018-04-01 to
2018-09-30
As at
2018-09-30
As at
2018-03-31
2017-04-01 to
2017-09-30
As at
2017-09-30
As at
2017-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
9,232,000,000 JPY
8,072,000,000 JPY
Interest and dividends received
220,000,000 JPY
208,000,000 JPY
Interest paid
-12,000,000 JPY
-13,000,000 JPY
Income taxes paid
-2,143,000,000 JPY
-1,007,000,000 JPY
Net cash provided by (used in) operating activities
7,297,000,000 JPY
7,260,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-877,000,000 JPY
-1,736,000,000 JPY
Proceeds from sale of property, plant and equipment
14,000,000 JPY
91,000,000 JPY
Purchase of investment securities
-500,000,000 JPY
-5,099,000,000 JPY
Other, net
-85,000,000 JPY
-77,000,000 JPY
Net cash provided by (used in) investing activities
-2,185,000,000 JPY
-3,928,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
202,000,000 JPY
799,000,000 JPY
Repayments of long-term borrowings
-1,165,000,000 JPY
-627,000,000 JPY
Dividends paid
-2,830,000,000 JPY
-2,831,000,000 JPY
Other, net
191,000,000 JPY
218,000,000 JPY
Net cash provided by (used in) financing activities
-3,627,000,000 JPY
-2,685,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
205,000,000 JPY
-9,000,000 JPY
Net increase (decrease) in cash and cash equivalents
1,689,000,000 JPY
637,000,000 JPY
Cash and cash equivalents
44,660,000,000 JPY
42,971,000,000 JPY
43,137,000,000 JPY
42,499,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.